| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |